speb/financial-data huggingface dataset:
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 140020000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 35176000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 1386000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 1386000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 16494000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 16494000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1696716000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1696716000.00
AKSHARCHEM.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 70742000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 131542000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Share Issued: 8033099.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 8033099.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 2637112000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2637112000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 2635651000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2635651000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Tax Provision: 10560000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -891000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.18
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 8927000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 8927000.00
AKSHARCHEM.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -2010000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Total Assets: 4153000000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 4153000000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 2770271000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 2770271000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Total Debt: 667667000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 667667000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 2637112000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2637108000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Total Expenses: 3354330000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 879910000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1515888000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1515888000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 2808944000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2808944000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 362066000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 362066000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 6811000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Work In Process: 79054000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 79054000.00
AKSHARCHEM.NS balance_sheet (annual, 2025-03-31) — Working Capital: 190234000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 190234000.00
AKSHARCHEM.NS income_statement (annual, 2025-03-31) — Write Off: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 388926000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 969623000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 7988764.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.89
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 556450000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 39886000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 39886000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 7988764.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.89
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — EBIT: 24611000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — EBITDA: 64497000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 413173000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 14288000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 14288000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -14288000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -14288000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 64497000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 7110000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Income: 24247000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 969623000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 364000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 313793000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 10323000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 556450000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 39886000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 3213000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.31
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 945376000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 386578000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 893024000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 631351000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 482502000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 20151000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 8052941.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Basic EPS: -1.70
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 80331000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1169000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 18770000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 80331000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 2621314000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 145436000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 523986000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 1365729000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 575679000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 575679000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1245168000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 3876000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 41072000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 41072000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 8052941.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.70
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -13690000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — EBIT: -239000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — EBITDA: 40833000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1372000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2831631000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 369038000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 13808000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 13808000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 696654000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 3366900000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 20151000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 169907000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 169907000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 6925000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 744417000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income: -13690000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -13690000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -13690000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -13690000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -13690000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -13690000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -13808000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -13808000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 2831631000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 2619942000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 225703000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 23872000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Normalized Income: -30219941.62
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Income: -17540000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 893024000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 8033099.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 155145000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 26810000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 2540983000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1372000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 50134000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 340000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 306220000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 2686195000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2985000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 17601000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Payables: 631351000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Pretax Income: -14047000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 523986000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 41072000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 8033099.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 16961000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2621314000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 2619942000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 431058.38
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -357000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.03
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 9673000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 4269017000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2791221000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 745586000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2621314000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 910564000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1647703000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2903288000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 402535000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 16961000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 16961000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 120561000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 357617000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 803787000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 8027130.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Basic EPS: -5.75
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 458794000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 41981000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 41981000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 8027130.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: -5.75
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — EBIT: -12170000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — EBITDA: 29811000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 344993000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 18529000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 18529000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -18529000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -18529000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 29811000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -46156000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Income: -12624000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 803787000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 454000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 279199000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -30699000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 458794000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 41981000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 15457000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 816411000.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — +Operating Expense: 1487817000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 354696000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — +Total Revenue: 3724300000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1057866000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 539467000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 539467000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 624070000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 624070000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 24183000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 24183000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 7974545.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 8031561.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Basic EPS: -0.55
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 6.02
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1444000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -359557000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 80331000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 80331000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1533000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1533000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 18026000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 18026000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -6044000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -25421000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Change In Payable: 2222000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -148220000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -169126000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 89000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 80331000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 80331000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 2615291000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 2615291000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 84235000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 84235000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2231691000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 692461000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 1513098000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 1513098000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 905811000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 905811000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 905811000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 905811000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1534630000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1534630000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 6707000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 6707000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation: 165281000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 165281000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 165281000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 42342000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 165281000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 42342000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 7974545.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 8031561.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Diluted EPS: -0.55
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 6.02
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -4386000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 48350000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 2000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — EBIT: 23731000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — EBIT: 11529000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — EBITDA: 189012000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 53871000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1533000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 341789000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -342875000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -84000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -61000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 933000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 933000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 2954478000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2954478000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Gross Profit: 1492609000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 365405000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense: 68162000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 21537000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 68162000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 21537000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -68162000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 1115000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Inventory: 730095000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 730095000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 3699939000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 3699939000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -358382000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 24183000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 24183000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 178837000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 178837000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 178837000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 178837000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 8354000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 8354000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 1083115000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 1083115000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Income: -4386000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income: 48350000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -4386000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 48350000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -4386000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 48350000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4386000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 48350000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4386000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 48350000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -44431000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -4386000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 48350000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -68162000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -21537000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -3000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 416981000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: 416981000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -68162000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -21537000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -986000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 2954478000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 2954478000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -359496000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 2614358000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2614358000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 178965000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 178965000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 172051000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 53871000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Normalized Income: -14562600.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 48350000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 16682000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Operating Income: 4792000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 10709000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 3724300000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1057866000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 8033099.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 8033099.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 126914000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 126914000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 39804000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 39804000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 2534960000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 2534960000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 933000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 933000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 66879000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 23385000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 23385000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 1978000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 820000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 1185137000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 285925000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2870243000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2870243000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 3290000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 3290000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 16493000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 16493000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Other Special Charges: -16961000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Payables: 539467000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 539467000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Pretax Income: -44431000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -10008000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -359557000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 2231691000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 692461000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 165281000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 42342000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 61000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 8033099.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 8033099.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Special Income Charges: 16961000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 2615291000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 2615291000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 2614358000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2614358000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 6784400.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Tax Provision: -40045000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -58358000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 10703000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 10703000.00
AKSHARCHEM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -1776000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 4516077000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 4516077000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 2794128000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2794128000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1084648000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1084648000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 2615291000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 2615291000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Total Expenses: 3719508000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1047157000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 1900786000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 1900786000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 3002979000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3002979000.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 366156000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 366156000.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 16961000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
AKSHARCHEM.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 16961000.00
AKSHARCHEM.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
AKSHARCHEM.NS balance_sheet (annual, 2026-03-31) — Working Capital: -21532000.00
AKSHARCHEM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: -21532000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Additional Paid In Capital: 3687000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Available For Sale Securities: 203000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Cash Equivalents: 1558000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Change In Working Capital: 1252000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Common Stock: 532000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Construction In Progress: 241000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Current Debt: 1434000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Deferred Tax: 271000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Depreciation: 1149000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Depreciation And Amortization: 1149000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Diluted EPS: 0.52
AKSO.OL balance_sheet (annual, 2021-12-31) — Finished Goods: 1000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: 11000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Goodwill: 4839000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Interest Expense: 383000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 383000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Interest Income: 242000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Interest Income Non Operating: 242000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Investment Properties: 658000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Investmentin Financial Assets: 203000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Long Term Debt: 925000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
AKSO.OL cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -352000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Net Income From Continuing Operations: 249000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Net Other Financing Charges: -49000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 885000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Other Investments: 203000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Other Special Charges: -129000000.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Properties: 0.00
AKSO.OL cash_flow (annual, 2021-12-31) — Purchase Of Investment: 0.00
AKSO.OL balance_sheet (annual, 2021-12-31) — Raw Materials: 293000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Reconciled Depreciation: 1149000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Repayment Of Debt: -352000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Sale Of Intangibles: 0.00
AKSO.OL cash_flow (annual, 2021-12-31) — Sale Of Investment: 1000000.00
AKSO.OL cash_flow (annual, 2021-12-31) — Taxes Refund Paid: -306000000.00
AKSO.OL income_statement (annual, 2021-12-31) — Total Operating Income As Reported: 693000000.00
AKSO.OL income_statement (annual, 2022-12-31) — +Operating Expense: 11785000000.00
AKSO.OL income_statement (annual, 2022-12-31) — +Total Revenue: 27302000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Accounts Payable: 2645000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Accounts Receivable: 5857000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -10414000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3687000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -69000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 25000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Basic Average Shares: 486899547.00
AKSO.OL income_statement (annual, 2022-12-31) — Basic EPS: 2.42
AKSO.OL cash_flow (annual, 2022-12-31) — Beginning Cash Position: 4560000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 7491000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Capital Expenditure: -620000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -113000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 4413000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Capital Stock: 532000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 6169000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 6169000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -97000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Cash Equivalents: 1503000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Cash Financial: 4666000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Change In Working Capital: 1793000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Changes In Cash: 1476000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Common Stock: 532000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -97000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Common Stock Equity: 9244000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Construction In Progress: 530000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Cost Of Revenue: 15636000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Current Assets: 19320000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 734000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Current Debt: 60000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 794000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Current Liabilities: 17679000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Current Provisions: 1719000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Deferred Tax: 545000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Depreciation: 1077000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1077000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Diluted Average Shares: 486899547.00
AKSO.OL income_statement (annual, 2022-12-31) — Diluted EPS: 2.42
AKSO.OL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1179000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 13000000.00
AKSO.OL income_statement (annual, 2022-12-31) — EBIT: 240000000.00
AKSO.OL income_statement (annual, 2022-12-31) — EBITDA: 1317000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 134000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — End Cash Position: 6170000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Financing Cash Flow: -2566000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Finished Goods: 1000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Free Cash Flow: 3898000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 9000000.00
AKSO.OL income_statement (annual, 2022-12-31) — General And Administrative Expense: 608000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Goodwill: 5038000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 5950000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 5926000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Gross PPE: 16150000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Gross Profit: 11666000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 406000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: -30000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Interest Expense: 290000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 290000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Interest Income: 105000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Interest Income Non Operating: 105000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Interest Paid Cff: -319000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Interest Received Cfi: 157000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Inventory: 275000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Invested Capital: 10266000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -476000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Investment Properties: 582000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 25000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 6000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 3679000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Long Term Debt: 962000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4641000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 6000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1450000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 103000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 8129000000.00
AKSO.OL balance_sheet (annual, 2022-12-31) — Minority Interest: -4000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Minority Interests: 8000000.00
AKSO.OL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -152000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Net Income: 1179000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1179000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -142000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 1312000000.00
AKSO.OL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1179000000.00